The binding of the selected Nbs to native Trop-2 has been verified by performing flow cytometry against various tumor cells or precipitation from cell lysates, which demonstrated their potential to target Trop-2 for in vivo application. This evidence concerns the gene TACSTD2 and neoplasm.